Skip to main content
. 2023 Sep 26;61(10):e00485-23. doi: 10.1128/jcm.00485-23

Fig 1.

Fig 1

Detection of drug resistance-conferring minority variants in M. tuberculosis isolates using LoFreq. DR: drug resistant (majority variants resistant to any first-line TB drug); DS: drug susceptible (majority variants susceptible to all first-line TB drugs); DR-MVs: drug-resistant minority variants; NSW: New South Wales; PCR: M. tuberculosis-specific polymerase chain reaction; TB: tuberculosis. *Group 1 (“Assoc W R”) drug-resistant variants, as in 2021 WHO Catalogue (23, 24). **Group 2 (“Assoc W R - Interim”) drug-resistant variants, as in 2021 WHO Catalogue (23, 24).